RFC4 and neoplasm: Silencing of RFC4 in various tumours, such as colon, breast and liver cancers, inhibits cells in S‐phase, preventing them from progressing to subsequent mitosis and proliferation, ultimately resulting in reduced tumour cell proliferation.12, 13, 14